Lifestance Health Group Inc
NASDAQ:LFST

Watchlist Manager
Lifestance Health Group Inc Logo
Lifestance Health Group Inc
NASDAQ:LFST
Watchlist
Price: 7.49 USD 0.67% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Lifestance Health Group Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one LFST stock under the Base Case scenario is 7.76 USD. Compared to the current market price of 7.49 USD, Lifestance Health Group Inc is Undervalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LFST Relative Value
Base Case
7.76 USD
Undervaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.4
P/S
P/S
Price to Sales
2.4
vs History
67
vs Industry
50
Median 3Y
2.8
Median 5Y
2.9
Industry
2.3
Forward
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-12.7
Median 5Y
-13.4
Industry
23.2
Forward
-37.7
More Details
46.4
P/OCF
P/OCF
Price to OCF
46.4
vs History
60
vs Industry
0
Median 3Y
74.2
Median 5Y
74.6
Industry
14.3
More Details
75.4
P/FCFE
P/FCFE
Price to FCFE
75.4
vs History
16
vs Industry
Median 3Y
-15.7
Median 5Y
-26.7
Industry
20.1
More Details
2
P/B
P/B
Price to Book Value
2
vs History
37
vs Industry
52
Median 3Y
1.8
Median 5Y
1.8
Industry
2.2
More Details
2.5
EV/S
EV/S
Enterprise Value to Sales
2.5
vs History
69
vs Industry
48
Median 3Y
3
Median 5Y
3.1
Industry
2.4
Forward
2.4
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5
More Details
206.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
206.9
vs History
6
vs Industry
2
Median 3Y
-19
Median 5Y
-15.6
Industry
12.8
Forward
29.4
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
2
Median 3Y
-13.9
Median 5Y
-15.3
Industry
17.2
Forward
-49.4
More Details
49.3
EV/OCF
EV/OCF
Enterprise Value to OCF
49.3
vs History
60
vs Industry
0
Median 3Y
78
Median 5Y
78.4
Industry
14
More Details
86.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
86.8
vs History
0
vs Industry
0
Median 3Y
-43.5
Median 5Y
-52.5
Industry
18.2
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
41
vs Industry
54
Median 3Y
1.4
Median 5Y
1.4
Industry
1.9
More Details

Multiples Across Competitors

LFST Competitors Multiples
Lifestance Health Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Lifestance Health Group Inc
NASDAQ:LFST
2.9B USD 2.4 -30.1 206.9 -47.7
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
Cigna Corp
NYSE:CI
77.9B USD 0.3 25.6 8 10.3
US
CVS Health Corp
NYSE:CVS
56B USD 0.2 11.2 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR 1.3 49 11.2 25.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49.2 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.3 13.2 20.4
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.4 12.3 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 24.5 7.1 16.4
US
DaVita Inc
NYSE:DVA
12.7B USD 1 15.4 8 11.1
P/E Multiple
Earnings Growth PEG
US
Lifestance Health Group Inc
NASDAQ:LFST
Average P/E: 27
Negative Multiple: -30.1 		N/A N/A
US
C
Cigna Group
XMUN:CGN
25.9
25%
1
US
Cigna Corp
NYSE:CI
25.6
25%
1
US
CVS Health Corp
NYSE:CVS
11.2
3%
3.7
DE
Fresenius Medical Care AG
XMUN:FME
49
31%
1.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.2 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.3
54%
0.8
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
253%
N/A
US
Quest Diagnostics Inc
NYSE:DGX
20.4
12%
1.7
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.5
31%
0.8
US
DaVita Inc
NYSE:DVA
15.4
17%
0.9

See Also

Summary
LFST intrinsic value, competitors valuation, and company profile.
DCF Valuation
LFST stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LFST stock valuation using valuation multiples.
Wall Street Estimates
LFST price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LFST stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.